From May 14 to 17, 2025, Strasbourg was the European capital of vascular innovation. For IDNEST Medical, participating in the European Symposium on Vascular Biomaterials (ESVB) “at home” was a highlight of this year.
This congress, recognized for its scientific excellence, was the ideal opportunity to present the progress of our technologies, and in particular our T-Stent solution, to a community of international experts.
A Successful Synergy between Clinical, Science and Engineering
What we retain above all from this 2025 edition is the quality of the exchanges. As our team on site highlighted, what a pleasure to see the clinical, scientific and engineering communities dialogue together around venous innovation!
It is precisely this interdisciplinarity that is at the heart of IDNEST Medical’s DNA. These discussions allow us to refine our devices so that they meet not only mechanical requirements (engineering) but above all the physiological realities of patients (clinical).
Acknowledgements and Perspectives
We would like to address a special thank you to GEPROMED and Prof. Nabil Chakfe for their active participation and the organization of this major event.
The presence and interventions of world-renowned experts, such as Dr. Peter Gloviczki, Prof. Olivier Hartung and Prof. Fabien Thaveau, enriched the debates on the future of medical devices.
ESVB 2025 confirmed that the IDNEST solution meets a real need. The positive feedback gathered at our booth encourages us to pursue our efforts to sustainably transform the management of Nutcracker Syndrome.